Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunomodulation by tacrolimus in atopic dermatitis].

Alain R Rodríguez Orozco1, Héctor Ruiz Reyes

  • 1Laboratorio de Inmunología, Universidad Michoacana de San Nicolás de Hidalgo. arorozco@hotmail.com

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|March 30, 2005
PubMed
Summary

Tacrolimus, an immunomodulator, shows promise in treating atopic dermatitis by impacting inflammatory markers. Further clinical studies are needed to confirm its long-term efficacy and safety in managing this complex allergic skin disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diazoxide and moderate-intensity exercise improve skeletal muscle function by decreasing oxidants and enhancing antioxidant defenses in hypertensive male rats.

Physiological reports·2024
Same author

[Family functioning and depression in mothers and children with atopic dermatitis].

Atencion primaria·2019
Same author

[Efficacy of two methods of administration of salbutamol-ipratropium bromide in asthma crises].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2009
Same author

[Administration of budesonide (inhaled steroid) to children to control intermittent asthma].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2009
Same author

[IL-4, IL-5 and IL-13 expression during in vitro immune response to fungal allergens in sensitized subjects].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2008
Same author

[Consultation profile and critical points in allergic patient attention at IMSS made by a non-allergologist specialist doctor].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2008

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Context:

  • Atopic dermatitis is a complex allergic skin condition with unclear immune responses to therapies.
  • Conventional and unconventional treatments for atopic dermatitis are being explored.
  • Immunomodulators are a class of drugs investigated for treating atopic dermatitis.

Purpose:

  • To review the clinical efficacy and safety of tacrolimus for atopic dermatitis treatment.
  • To assess the impact of tacrolimus on inflammatory markers in atopic dermatitis.
  • To identify the need for further long-term clinical trials on tacrolimus.

Summary:

  • Tacrolimus, an immunomodulator, demonstrates a significant impact on inflammatory markers in atopic dermatitis.
  • Clinical evidence suggests tacrolimus is a potential treatment option for atopic dermatitis.

Related Experiment Videos

  • The review highlights the need for extensive clinical assays to ascertain tacrolimus's long-term toxicity and efficacy profiles.

    • Impact:

    • Tacrolimus may offer a new therapeutic avenue for managing atopic dermatitis.
    • Understanding tacrolimus's effects on immune responses can guide future treatment strategies.
    • Further research on tacrolimus is crucial for establishing its role in atopic dermatitis management.